Quest Diagnostics Q1 2025 10-Q Filed
Ticker: DGX · Form: 10-Q · Filed: Apr 23, 2025 · CIK: 1022079
| Field | Detail |
|---|---|
| Company | Quest Diagnostics Inc (DGX) |
| Form Type | 10-Q |
| Filed Date | Apr 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
TL;DR
Quest Diagnostics Q1 2025 10-Q is in. Financials for Jan-Mar 2025 vs 2024 detailed.
AI Summary
Quest Diagnostics Inc. filed its 10-Q for the period ending March 31, 2025. The filing includes financial data for the first quarter of 2025, comparing it to the same period in 2024. Specific financial statement line items and balance sheet accounts are detailed, such as common stock, retained earnings, and accumulated other comprehensive income.
Why It Matters
This filing provides investors with the latest financial performance and position of Quest Diagnostics, crucial for understanding the company's health and future prospects.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate red flags.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Latest financial data available)
- 2025-04-23 — Filing Date (When the report was submitted to the SEC)
- 2025-01-01 to 2025-03-31 — Q1 2025 Period (First quarter financial performance)
- 2024-01-01 to 2024-03-31 — Q1 2024 Period (Comparative first quarter financial performance)
Key Players & Entities
- Quest Diagnostics Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of reporting period
- 20250423 (date) — Filing date
- 2025-01-01 (date) — Start of Q1 2025
- 2024-01-01 (date) — Start of Q1 2024
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on April 23, 2025.
What fiscal year end does Quest Diagnostics report?
Quest Diagnostics reports a fiscal year end of December 31.
What are some of the balance sheet accounts detailed in the filing?
The filing details accounts such as Common Stock, Additional Paid-In Capital, Retained Earnings, Accumulated Other Comprehensive Income, Treasury Stock, and Noncontrolling Interest.
What periods are being compared in this filing?
This filing compares financial data for the period January 1, 2025, to March 31, 2025, with the period January 1, 2024, to March 31, 2024.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on April 23, 2025 regarding QUEST DIAGNOSTICS INC (DGX).